“Grafts were harvested at 7, 14, 28, 56, 100, 180, 232, and 365 days after grafting.”
✓ VerifiedFDA pharmacology/toxicology review, p. 17Source ↗
Pivotal GLP studies
No GLP repeat-dose tox; GLP ISO-10993 biocompatibility tests (systemic, subchronic subcutaneous in rabbits) and non-GLP nude mouse graft studies
“The potential toxicity of Apligraf® was evaluated via studies that reflect the initial medical device framework (i.e., biocompatibility testing in conformance to ISO-10993 standards).”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗
Route in tox
Topical graft (mouse); intraperitoneal, intravenous, intracutaneous, subcutaneous extracts in biocompatibility
“Sub-chronic Toxicity (Subcutaneous Injection Test – Subchronic)”
✓ VerifiedFDA pharmacology/toxicology review, p. 46Source ↗